Unknown PHASE2 INTERVENTIONAL 2-arm NCT04436081

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

Sponsor: Ananda Hemp, Inc.

Conditions Alzheimer Disease Dementia Major Neurocognitive Disorder With Aggressive Behavior

Updated 11 times since 2020 Last updated: Feb 15, 2023 Started: Feb 26, 2021 Primary completion: Mar 31, 2024 Completion: Mar 31, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04436081, this PHASE2 trial focuses on Alzheimer Disease and Dementia and remains ongoing. Sponsored by Ananda Hemp, Inc., it has been updated 11 times since 2021, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

11 versions recorded

Mar 2025 — Present [monthly]

Unknown PHASE2

Status: Recruiting → Unknown
Sep 2024 — Mar 2025 [monthly]

Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE2
Mar 2023 — Jul 2024 [monthly]

Recruiting PHASE2
Jun 2022 — Mar 2023 [monthly]

Recruiting PHASE2

▶ Show 6 earlier versions

Apr 2022 — Jun 2022 [monthly]

Recruiting PHASE2
Sep 2021 — Apr 2022 [monthly]

Recruiting PHASE2
Apr 2021 — Sep 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Mar 2021 — Apr 2021 [monthly]

Not Yet Recruiting PHASE2
Jan 2021 — Mar 2021 [monthly]

Not Yet Recruiting PHASE2
Jul 2020 — Jan 2021 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ananda Hemp, Inc.
Eastern Virginia Medical School
Old Dominion University

Data source: Eastern Virginia Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Norfolk, United States